LACK OF NF1 EXPRESSION IN A SPORADIC SCHWANNOMA FROM A PATIENT WITHOUT NEUROFIBROMATOSIS

被引:3
作者
GUTMANN, DH
SILOSSANTIAGO, I
GEIST, RT
DARAS, M
RUTKOWSKI, JL
机构
[1] WASHINGTON UNIV,SCH MED,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO
[2] WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110
[4] NEW YORK MED COLL,DEPT NEUROL,NEW YORK,NY
[5] UNIV MICHIGAN,SCH MED,DEPT PEDIAT NEUROL,ANN ARBOR,MI
关键词
NEUROFIBROMIN; SCHWANN CELLS; TUMOR SUPPRESSOR GENE; NEUROFIBROMATOSIS;
D O I
10.1007/BF01057754
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The neurofibromatosis type 1 (NF1) gene encodes a tumor suppressor protein, neurofibromin, which is expressed at high levels in Schwann cells and other adult tissues. Loss of NF1 expression has been reported in Schwann cell tumors (neurofibrosarcomas) from patients with NF1 and its loss is associated with increased Proliferation of these cells. In this report, we describe downregulation of NF1 expression in a single spinal schwannoma from an individual without clinical features of neurofibromatosis type 1 or 2. Barely detectable expression of NF1 RNA. was found in this tumor by in situ hybridization using an NF1-specific riboprobe as well as by Northern blot and reverse-transcribed (RT)-PCR analysis. In Schwann cells cultured from this schwannoma, abundant expression of NF1 RNA could be detected by Northern blot and RT-PCR analysis. These results suggest that, in some tumors, expression of NF1 may be downregulated by factors produced within the tumor and may represent a novel mechanism for inactivating these growth suppressing genes and allowing for increased cell proliferation in tumors.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 25 条
[1]   A CONSERVED ALTERNATIVE SPLICE IN THE VONRECKLINGHAUSEN NEUROFIBROMATOSIS (NF1) GENE PRODUCES 2 NEUROFIBROMIN ISOFORMS, BOTH OF WHICH HAVE GTPASE-ACTIVATING PROTEIN-ACTIVITY [J].
ANDERSEN, LB ;
BALLESTER, R ;
MARCHUK, DA ;
CHANG, E ;
GUTMANN, DH ;
SAULINO, AM ;
CAMONIS, J ;
WIGLER, M ;
COLLINS, FS .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :487-495
[2]  
BADER JL, 1986, ANN NY ACAD SCI, V486, P57
[3]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[4]   MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES [J].
BIANCHI, AB ;
HARA, T ;
RAMESH, V ;
GAO, JZ ;
KLEINSZANTO, AJP ;
MORIN, F ;
MENON, AG ;
TROFATTER, JA ;
GUSELLA, JF ;
SEIZINGER, BR ;
KLEY, N .
NATURE GENETICS, 1994, 6 (02) :185-192
[5]   GERMLINE MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR GENE [J].
BOURN, D ;
CARTER, SA ;
MASON, S ;
EVANS, DGR ;
STRACHAN, T .
HUMAN MOLECULAR GENETICS, 1994, 3 (05) :813-816
[6]   THE PROTEIN PRODUCT OF THE NEUROFIBROMATOSIS TYPE-1 GENE IS EXPRESSED AT HIGHEST ABUNDANCE IN NEURONS, SCHWANN-CELLS, AND OLIGODENDROCYTES [J].
DASTON, MM ;
SCRABLE, H ;
NORDLUND, M ;
STURBAUM, AK ;
NISSEN, LM ;
RATNER, N .
NEURON, 1992, 8 (03) :415-428
[7]   ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS [J].
DECLUE, JE ;
PAPAGEORGE, AG ;
FLETCHER, JA ;
DIEHL, SR ;
RATNER, N ;
VASS, WC ;
LOWY, DR .
CELL, 1992, 69 (02) :265-273
[8]  
EVANS DGR, 1992, Q J MED, V304, P603
[9]   THE NEUROFIBROMATOSIS TYPE-1 GENE AND ITS PROTEIN PRODUCT, NEUROFIBROMIN [J].
GUTMANN, DH ;
COLLINS, FS .
NEURON, 1993, 10 (03) :335-343
[10]   MODULATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE-PRODUCT, NEUROFIBROMIN, DURING SCHWANN-CELL DIFFERENTIATION [J].
GUTMANN, DH ;
TENNEKOON, GI ;
COLE, JL ;
COLLINS, FS ;
RUTKOWSKI, JL .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 36 (02) :216-223